S6: asthma, COPD, bronchiectasis & cystic fibrosis Flashcards
What is asthma?
Chronic inflammatory disorder of the airways
Inflammatory symptoms are usually associated with widespread but variable airflow obstruction and an increase in airway responsiveness to a variety of stimuli
Characterised by a triad of bronchial smooth muscle contraction, airway inflammation & increased secretions
Describe the difference in reversibility after bronchodilator use in asthma and COPD
Asthma: airway obstruction in asthma is often reversible – improvement in FEV1 of 12% or more after bronchodilators
COPD: airways obstruction is not fully reversible - < 12% improvement FEV1 on spirometry after bronchodilators
Describe the pathophysiology of asthma
Initially a type 1 hypersensitivity reaction (immediate response)
Allergen -> dendritic cell -> CD4+ cells -> Th2 cell
Th2 cells activate B-lymphocytes (also activated by re-exposure of allergen) & eosinophils
B-lymphocytes -> plasma cells -> IgE -> mast cells have receptor (Fc)
Mast cell degranulation – histamine, cytokines, leukotrienes & eosinophils secrete leukotrienes & cytokines -> these both cause inflammation and bronchoconstriction
List asthma triggers
Allergens – pollen, animals Cold air GORD Exercise Fumes – car exhaust Cigarette smoke
Describe what long term poorly controlled asthma can lead to
Airway remodelling, some of which may not be fully reversible
Changes include:
-hypertrophy & hyperplasia of smooth muscle
-hypertrophy of mucus glands
-thickening of basement membrane
Describe the effect of airways narrowing in asthma
Causes wheezing & other clinical features of asthma
Results in an obstructive pattern on spirometry & typical flow volume loops
Air trapping with increased residual volume & hence increased functional reserve capacity
Describe the effect on gas exchange in asthma
Airway narrowing -> reduced ventilation of the affected alveoli -> V/P mismatch
In unmanaged mild to moderate asthma: decreased pCO2 & pO2 = type 1 respiratory failure
Severe attacks: extensive involvement of airways with complete blockage of some airways & exhaustion (limits respiratory effort) -> limits the amount of CO2 which can be breathed out
Increasing pCO2 is a sign of LIFE-THREATENING ASTHMA
Describe signs and symptoms of asthma
Dry, nocturnal cough Wheeze Breathlessness Chest tightness Atopy
Describe the management of asthma
Step 1: short acting beta-2 agonist (finger tremor is a side effect), bronchial smooth muscle relaxation (blue inhaler)
Inhaled corticosteroid – anti-inflammatory (brown inhaler)
Step 2: combination inhaler – long acting beta-2 agonist & anti-inflammatory
Step 3: can increase dose of inhaled corticosteroid or add leukotriene receptor antagonist
Step 4: specialist care
Describe the emergency management of asthma
Oxygen
Short acting beta-2 agonist
Steroids
ADMIT
What is COPD?
A disease characterised by persistent respiratory symptoms & airflow limitation
Due to airways and/or alveolar abnormalities
Caused by significant exposure to noxious particles or gases
Describe the pathophysiology of COPD
Small airways disease – airway inflammation, airway fibrosis, luminal plugs
Parenchymal destruction – loss of alveolar attachments, decrease of elastic recoil
Both lead to airflow limitation
Describe emphysema and chronic bronchitis
Emphysema – elastin breakdown & subsequent loss of alveolar integrity leading to permanent destructive enlargement of the airspaces distal to the terminal bronchioles
Chronic bronchitis – excessive mucous secretion and impaired removal of the secretions
Describe the diagnosis of COPD
Symptoms: shortness of breath, chronic cough & sputum
Risk factors: host factors, tobacco, occupation & indoor/outdoor pollution
Spirometry: required to establish diagnosis
List the signs of COPD
Often few or none especially at rest Purse lip breathing Hyperinflation/barrel-shaped chest Prolonged expiratory phase Wheeze on auscultation Late features include cyanosis & right-sided heart failure